• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中p53表达与预后因素相关。

p53 expression in breast cancer related to prognostic factors.

作者信息

Ciesielski D, Dziewulska-Bokiniec A, Zółtowska A, Roszkiewicz A, Kopacz A, Wojtacki J

机构信息

Department of Immunopathology, Medical University of Gdańsk, Poland.

出版信息

Neoplasma. 1995;42(5):235-7.

PMID:8552201
Abstract

In this article the results of molecular marker p53 examinations were presented in relation to the following established breast cancer prognostic factors: age, histologic type, histologic grade, lymph node involvement, tumor size as well as estrogen a progesterone receptor status. Twenty one percent of these primary breast cancer specimens exhibited the overexpression of p53 protein. Significant associations were found between p53 overexpression and younger age, high histologic grade and low content of estrogen and progesterone receptors. Identification of p53-positive breast carcinomas potentially represents a clinically useful indicator of breast cancer aggressiveness.

摘要

在本文中,呈现了分子标志物p53检测结果与以下已确立的乳腺癌预后因素的关系:年龄、组织学类型、组织学分级、淋巴结受累情况、肿瘤大小以及雌激素和孕激素受体状态。这些原发性乳腺癌标本中有21%表现出p53蛋白过表达。发现p53过表达与较年轻的年龄、高组织学分级以及雌激素和孕激素受体低含量之间存在显著关联。p53阳性乳腺癌的鉴定可能代表了一种临床上有用的乳腺癌侵袭性指标。

相似文献

1
p53 expression in breast cancer related to prognostic factors.乳腺癌中p53表达与预后因素相关。
Neoplasma. 1995;42(5):235-7.
2
Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.人乳腺癌中突变型p53表达及DNA分析与传统临床病理参数的比较
Anticancer Res. 1995 Mar-Apr;15(2):581-6.
3
Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.对DNA倍体、p53、c-erbB-2蛋白、表皮生长因子受体(EGFR)和类固醇激素受体进行多变量分析,以预测乳腺癌短期预后不良。
Anticancer Res. 1997 Mar-Apr;17(2B):1417-23.
4
Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.科威特年轻女性乳腺癌中p53蛋白表达的免疫组织化学检测
Anticancer Res. 2001 Jan-Feb;21(1B):743-8.
5
p53 protein expression in human breast carcinoma: lack of prognostic potential for recurrence of the disease.人乳腺癌中p53蛋白表达:对疾病复发缺乏预后预测价值
Anticancer Res. 1996 May-Jun;16(3A):1301-4.
6
p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study.人乳腺癌中p53表达与生存及预后因素的关系:一项免疫组织化学研究
J Pathol. 1991 May;164(1):75-81. doi: 10.1002/path.1711640113.
7
Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.原发性导管浸润性乳腺癌及其腋窝淋巴结转移灶中的肿瘤生长分数、雌激素和孕激素受体表达、p53、bcl-2以及组织蛋白酶D活性
Coll Antropol. 2007 Dec;31(4):1043-7.
8
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.p53和c-erbB-2的同时过度表达与淋巴结阴性乳腺癌的细胞周期加速及预后不良相关。
Hum Pathol. 2001 Mar;32(3):311-9. doi: 10.1053/hupa.2001.22748.
9
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.在接受多柔比星和环磷酰胺序贯紫杉醇辅助化疗的III期乳腺癌患者中,bcl-2表达的预后意义
BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63.
10
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.淋巴结阴性乳腺癌中三阴性的临床病理特征及预后意义
BMC Cancer. 2008 Oct 23;8:307. doi: 10.1186/1471-2407-8-307.

引用本文的文献

1
Clinical Validation of BCT Scores With Prognostic Factors in Hormone Receptor-positive, HER2-negative Early Breast Cancer.激素受体阳性、HER2 阴性早期乳腺癌中 BCT 评分与预后因素的临床验证。
In Vivo. 2019 Nov-Dec;33(6):2133-2139. doi: 10.21873/invivo.11714.